Stay updated with breaking news from Timothys Ernst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thompson Siegel & Walmsley LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 960.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 201,222 shares of the medical research company’s stock after purchasing an additional 182,248 shares during the […]
StockNews.com started coverage on shares of Bio-Rad Laboratories (NYSE:BIO – Get Rating) in a report released on Thursday. The brokerage issued a buy rating on the medical research company’s stock. Other equities analysts have also issued reports about the stock. Royal Bank of Canada raised their target price on shares of Bio-Rad Laboratories from $571.00 […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) shares saw unusually-high trading volume on Monday . Approximately 64,548 shares changed hands during mid-day trading, a decline of 64% from the previous session’s volume of 177,345 shares.The stock last traded at $383.72 and had previously closed at $382.14. Analysts Set New Price Targets BIO has been the […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 236,400 shares, a decline of 13.8% from the April 15th total of 274,400 shares. Currently, 1.1% of the company’s shares are sold short. Based […]
WASHINGTON TRUST Co lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 62.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 78 shares of the medical research company’s stock after purchasing an additional 30 shares during […]